Liabilities / Assets
65th percentile
Higher debt load relative to assets than 65% of similar nonprofits.
Watching Over Mothers & Babies Foundation
990EZ • Fiscal year 2019 • EIN 52-2420995
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.01x
Liabilities / Revenue
71st percentile
Higher debt load relative to revenue than 71% of similar nonprofits.
Net Margin
5th percentile
Higher net margin than 5% of similar nonprofits.
Top Officer Pay
77th percentile
Higher top officer pay than 77% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
14th percentile
Faster asset growth than 14% of similar nonprofits.
Revenue Growth
6th percentile
Faster revenue growth than 6% of similar nonprofits.
Balance Sheet
Assets
Down$194,423
Down $101,306 (-34%) from 2018
Net Assets
Down$192,171
Down $103,558 (-35%) from 2018
Liabilities
Up$2,252
Up $2,252 from 2018
Revenue And Expenses
Revenue
Down$100,550
Down $182,936 (-65%) from 2018
Expenses
Down$203,335
Down $35,600 (-15%) from 2018
Net Income
Down-$102,785
Down $147,336 (-331%) from 2018
Historical Trend
Jump To
Filing Snapshot
- Filing Period
- Jul 1, 2018 to Jun 30, 2019
- Signed
- Jul 15, 2020
- Return Version
- 2018v3.1
- Gross Receipts
- $100,550
Mission and Program Overview
Mission
The Watching Over Mothers & Babies Foundation (WOMB) is partnering with local and national organizations to address a broad array of health problems that continue to impact women and their children.
The Watching Over Mothers & Babies Foundation (WOMB) helps mothers with perinatal health problems, and is partnering with local and national organizations to address a broad array of perinatal health problems.
Program Services
| Description | Grants | Expenses |
|---|---|---|
| The Watching Over Mothers & Babies (WOMB) foundation conducts research in partnership to improve the health and options for pregnant women and children. These efforts serve to offer better treatments for pregnant women and children in the pursuit of improving perinatal & neonatal outcomes. Historically WOMB was engaged in a combination of innovative research devoted to the treatment of tobacco use in pregnancy in an effort to increase cessation rates among pregnant women. While that goal remains, WOMB has diversified and is committed to addressing other important health initiatives most recently WOMB has applied for research funding to apply several of the same principles to opioid dependence disorder in an effort to better manage opioid use in pregnancy.WOMB is still evaluating its success with motivational counseling directed at the pregnant women and her partner to assist in the smoking cessation. This project is called family alliance and its use of motivational counseling isBeing compared to the standard prescriptive techniques more commonly used in clinical practice. The Arizona disease control research commission, now called the Arizona Biomedical research commission provided the early funding for this trial. In the early phase of this study, Dr. Miller was still full-time faculty at the University of Arizona, however upon leaving his position, he desired to continue this work through the creation of the WOMB foundation which has continued to support it over the years.WOMB is completing its data analysis and will be publishing the results of a NIH funded pilot RCT utilizing bupropion as a cessation aide in conjunction with counseling. WOMB has also started the process of exploring other initiatives in the concerted goal of reducing tobacco use in pregnancy, both primary and secondary.In the past several years WOMB has been involved in research focused on reducing the risk of RSV by immunizing pregnant women and conveying passive immunity as we do with several other viral infections such as influenza and pertussis. The goal of significantly reducing RSV bridges the maternal-neonatal fields which historically has been difficult to do.Other active research activities include:1. Cook study: RCT comparing the CRB with pitocin to pitocin alone in premature rupture of membranes (prom) patients with an unfavorable cervix was completed this year and data analysis is ongoing. We expect to present the results at the annual SMFM meeting in 2021.2. Actim partus test: is a study designed to evaluate a new diagnostic technology to detect preterm labor at an early stage where it might be treated avoiding the serious consequences of a preterm birth (ptb). This study was also completed and is under review by the FDA.3. Novavax has been working with the who/gates foundation to develop a RSV vaccine: a phase 3, randomized, observer-blind, placebo-controlled, group-sequential study to determine the immunogenicity and safety of a respiratory syncytial virus (RSV) f nanoparticle vaccine with aluminum in healthy third-trimester pregnant women; and safety and efficacy of maternally transferred antibodies in preventing RSV disease in their infants. Study enrollment was also completed this year, but long-term outcomes are still being collected.4. Pfizer has been developing its own RSV vaccine and launched an RCT in 2018. A Phase 2b randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of a respiratory syncytial virus (RSV) perfusion F subunit vaccine in infants born to women vaccinated during pregnancy.5. WOMB places a premium on breast feeding and supporting women in that goal but we also recognize for a variety of reasons there is a significant number of women who are unable or unwilling to breast feed. Their children deserve the best nutritional option and those choices can only be determined with ongoing research in this area. WOMB continues to participate in several Abbott formula studies designed to improve the nutritional characteristics of their formulas for specific neonatal populations. The studies are designed to test new milk-based formulas fortified with specific supplements to meet specific needs of term and preterm infants for whom breast feeding is not an option. The study is looking at multiple markers for nutrition, gi toleration and growth.6. Common sense has developed an innovative approach to diagnose preterm rupture of membranes that might ultimately permit many women to better evaluate their status prior to presenting to the hospital. The purpose of this study was to compare this new technology with the current standard of care. This study has been concluded and the results are under review by the FDA.7. WOMB was one of the USA sites that participated in the prolong trial. USA enrollment was suspended several years ago but the international enrollment was completed in 2018, and the study results were analyzed and published just prior to their presentation to the FDA in October 2019. | $179,764 | - |
Compensation and Service Providers
Employees
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| Dr Hugh Miller | President/CEO | PT | $0 | - | - |
| Michay Brown | COO/Counsel | PT | $0 | - | - |
| Dr Monica Casper | Secretary/Treas | - | $0 | - | - |
| Kennth Ramos | Member | - | $0 | - | - |
| Ralph Fregosi | Member | - | $0 | - | - |
| Penny Bussell-Stansfield | Member | - | $0 | - | - |
Filing and Contact Details
Filer
- Filer Name
- Watching Over Mothers & Babies
- EIN
- 52-2420995
- Phone
- 5208829662
- Address
- 5245 E KNIGHT DRIVE, TUCSON, AZ 85712
Signing Officer
- Name
- Dr Hugh Miller
- Title
- CEO
- Signed
- 2020-07-15
- Discuss with paid preparer
- Yes
Preparer
- Firm
- HBL CPAs PC
- Address
- 5470 E Broadway Blvd, Tucson, AZ 85711
- Preparer
- Michael J Devries
- Phone
- 5208863181
Supplemental Narrative
Additional Explanations
Other Expenses.1002
“Office Expenses $7536”
Other Expenses.1009
“Depreciation $1477”
Other Expenses.1012
“Insurance $5968”
Other Expenses.1
“RESEARCH STUDIES $5255”
Other Expenses.3
“DUES $158”
Other Expenses.4
“MEALS & LODGING $44”
Other Assets.1003
“Machinery and Equipment - Beginning $4726 Machinery and Equipment - Ending $3249”
Other Assets.1005
“Accounts Receivable - Beginning $2621 Accounts Receivable - Ending $0”
Total Liabilities.1001
“Accounts Payable and Accrued Expenses - Beginning $0 Accounts Payable and Accrued Expenses - Ending $50”
Total Liabilities.1
“CREDIT CARDS PAYABLE - Beginning $0 CREDIT CARDS PAYABLE - Ending $430”
Total Liabilities.2
“PAYROLL TAXES PAYABLE - Beginning $0 PAYROLL TAXES PAYABLE - Ending $1772”
Raw XML Appendix147 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/PersonNm | 0 | THE ORGANIZATION |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 5208829662 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 5245 E KNIGHT DRIVE |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | TUCSON |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | AZ |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 85712 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 288382 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 191174 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/CostOfGoodsSoldAmt | 0 | 0 |
| IRS990EZ/CostOrOtherBasisExpenseSaleAmt | 0 | 0 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | -102785 |
| IRS990EZ/FeesAndOtherPymtToIndCntrctAmt | 0 | 15741 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form720FiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 295729 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 194423 |
| IRS990EZ/FundraisingGrossIncomeAmt | 0 | 0 |
| IRS990EZ/GrossReceiptsAmt | 0 | 100550 |
| IRS990EZ/GrossReceiptsForPublicUseAmt | 0 | 0 |
| IRS990EZ/InfoInScheduleOPartIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/InitiationFeesAndCapContriAmt | 0 | 0 |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MethodOfAccountingAccrualInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 295729 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 192171 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 295729 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 192171 |
| IRS990EZ/OccupancyRentUtltsAndMaintAmt | 0 | 32916 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 30.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 20.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 0.20 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 0.20 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 4 | 0.20 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 5 | 0.20 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 5 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | Dr Hugh Miller |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | Michay Brown |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | Dr Monica Casper |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | Kennth Ramos |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 4 | Ralph Fregosi |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 5 | Penny Bussell-Stansfield |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | President/CEO |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | COO/Counsel |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | Secretary/Treas |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | Member |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 4 | Member |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 5 | Member |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationFiled990TInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherAssetsTotalDetail/BOYAmt | 0 | 7347 |
| IRS990EZ/OtherAssetsTotalDetail/EOYAmt | 0 | 3249 |
| IRS990EZ/OtherChangesInNetAssetsAmt | 0 | -773 |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 20438 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | The Watching Over Mothers & Babies Foundation (WOMB) helps mothers with perinatal health problems, and is partnering with local and national organizations to address a broad array of perinatal health problems. |
| IRS990EZ/PrintingPublicationsPostageAmt | 0 | 265 |
| IRS990EZ/ProgramServiceRevenueAmt | 0 | 100550 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | The Watching Over Mothers & Babies (WOMB) foundation conducts research in partnership to improve the health and options for pregnant women and children. These efforts serve to offer better treatments for pregnant women and children in the pursuit of improving perinatal & neonatal outcomes. Historically WOMB was engaged in a combination of innovative research devoted to the treatment of tobacco use in pregnancy in an effort to increase cessation rates among pregnant women. While that goal remains, WOMB has diversified and is committed to addressing other important health initiatives most recently WOMB has applied for research funding to apply several of the same principles to opioid dependence disorder in an effort to better manage opioid use in pregnancy.WOMB is still evaluating its success with motivational counseling directed at the pregnant women and her partner to assist in the smoking cessation. This project is called family alliance and its use of motivational counseling isBeing compared to the standard prescriptive techniques more commonly used in clinical practice. The Arizona disease control research commission, now called the Arizona Biomedical research commission provided the early funding for this trial. In the early phase of this study, Dr. Miller was still full-time faculty at the University of Arizona, however upon leaving his position, he desired to continue this work through the creation of the WOMB foundation which has continued to support it over the years.WOMB is completing its data analysis and will be publishing the results of a NIH funded pilot RCT utilizing bupropion as a cessation aide in conjunction with counseling. WOMB has also started the process of exploring other initiatives in the concerted goal of reducing tobacco use in pregnancy, both primary and secondary.In the past several years WOMB has been involved in research focused on reducing the risk of RSV by immunizing pregnant women and conveying passive immunity as we do with several other viral infections such as influenza and pertussis. The goal of significantly reducing RSV bridges the maternal-neonatal fields which historically has been difficult to do.Other active research activities include:1. Cook study: RCT comparing the CRB with pitocin to pitocin alone in premature rupture of membranes (prom) patients with an unfavorable cervix was completed this year and data analysis is ongoing. We expect to present the results at the annual SMFM meeting in 2021.2. Actim partus test: is a study designed to evaluate a new diagnostic technology to detect preterm labor at an early stage where it might be treated avoiding the serious consequences of a preterm birth (ptb). This study was also completed and is under review by the FDA.3. Novavax has been working with the who/gates foundation to develop a RSV vaccine: a phase 3, randomized, observer-blind, placebo-controlled, group-sequential study to determine the immunogenicity and safety of a respiratory syncytial virus (RSV) f nanoparticle vaccine with aluminum in healthy third-trimester pregnant women; and safety and efficacy of maternally transferred antibodies in preventing RSV disease in their infants. Study enrollment was also completed this year, but long-term outcomes are still being collected.4. Pfizer has been developing its own RSV vaccine and launched an RCT in 2018. A Phase 2b randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of a respiratory syncytial virus (RSV) perfusion F subunit vaccine in infants born to women vaccinated during pregnancy.5. WOMB places a premium on breast feeding and supporting women in that goal but we also recognize for a variety of reasons there is a significant number of women who are unable or unwilling to breast feed. Their children deserve the best nutritional option and those choices can only be determined with ongoing research in this area. WOMB continues to participate in several Abbott formula studies designed to improv |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt | 0 | 179764 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/RelatedOrgSect527OrgInd | 0 | false |
| IRS990EZ/SalariesOtherCompEmplBnftAmt | 0 | 133975 |
| IRS990EZ/ScheduleBNotRequiredInd | 0 | X |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/SpecialEventsDirectExpensesAmt | 0 | 0 |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt | 0 | 2252 |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 203335 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 179764 |
| IRS990EZ/TotalRevenueAmt | 0 | 100550 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | WWW.WOMB.ORG |
| IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm | 0 | Tucson |
| IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd | 0 | AZ |
| IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt | 0 | Tucson Medical Center |
| IRS990ScheduleA/MedicalResearchOrganizationInd | 0 | X |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | Office Expenses $7536 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | Depreciation $1477 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | Insurance $5968 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | RESEARCH STUDIES $5255 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | DUES $158 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 5 | MEALS & LODGING $44 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 6 | Machinery and Equipment - Beginning $4726 Machinery and Equipment - Ending $3249 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 7 | Accounts Receivable - Beginning $2621 Accounts Receivable - Ending $0 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 8 | Accounts Payable and Accrued Expenses - Beginning $0 Accounts Payable and Accrued Expenses - Ending $50 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 9 | CREDIT CARDS PAYABLE - Beginning $0 CREDIT CARDS PAYABLE - Ending $430 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 10 | PAYROLL TAXES PAYABLE - Beginning $0 PAYROLL TAXES PAYABLE - Ending $1772 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | Other Expenses.1002 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | Other Expenses.1009 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | Other Expenses.1012 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | Other Expenses.1 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | Other Expenses.3 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 5 | Other Expenses.4 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 6 | Other Assets.1003 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 7 | Other Assets.1005 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 8 | Total Liabilities.1001 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 9 | Total Liabilities.1 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 10 | Total Liabilities.2 |
| ReturnHeader/BuildTS | 0 | 2021-01-29 14:40:06Z |
| ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd | 0 | true |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | Dr Hugh Miller |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | CEO |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2020-07-15 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | WATCHING OVER MOTHERS & BABIES |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | WATC |
| ReturnHeader/Filer/EIN | 0 | 522420995 |
| ReturnHeader/Filer/PhoneNum | 0 | 5208829662 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 5245 E KNIGHT DRIVE |
| ReturnHeader/Filer/USAddress/CityNm | 0 | TUCSON |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | AZ |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 85712 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 860360084 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | HBL CPAs PC |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 5470 E Broadway Blvd |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | Tucson |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | AZ |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 85711 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 5208863181 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | MICHAEL J DEVRIES |
| ReturnHeader/ReturnTs | 0 | 2020-07-15T13:15:23-07:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2018-07-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2019-06-30 |
| ReturnHeader/TaxYr | 0 | 2018 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2019 • Form 990EZDetailed filing. Detailed filing data is available for this year.
- Assets
- $194,423
- Liabilities
- $2,252
- Net assets
- $192,171
- Revenue
- $100,550
- Expenses
- $203,335
- Net income
- -$102,785